文档介绍：肝爽颗粒联合恩替卡韦抗病毒治疗乙肝肝硬化的临床效果
房荣马小勇
陕西省延安市人民医院感染科
X
关注成功!
加关注后您将方便地在我的关注中得到本文献的被引频次变化的通知!
新浪微博
腾讯微博
人人网
开心网
豆瓣网
网易微博
摘    要:
目的探讨肝爽颗粒联合恩替卡韦抗病毒治疗乙肝肝硬化患者的临床效果。方法将我院收治的132例乙肝肝硬化患者按照入院时间分为对照组和观察组, 每组66例。对照组患者给予恩替卡韦抗病毒治疗, 观察组患者给予肝爽颗粒+恩替卡韦抗病毒治疗。比较两组患者的临床效果。%, % (P<) ;治疗后, 两组患者的AST、ALB、ALT、TBIL、LN、PCⅢ、Ⅳ-C及HA水平明显优于治疗前, 且观察组明显优于对照组(P<) 。结论应用肝爽颗粒联合恩替卡韦抗病毒治疗乙肝肝硬化可更好地改善患者的肝功能, 可取得满意的临床效果, 值得临床推广应用。
关键词:
肝爽颗粒; 恩替卡韦; 乙肝肝硬化;
作者简介:房荣(1971-) , 男, 汉族, 山东菏泽人, 副主任医师, 学士。研究方向:结核病。
Clinical effect of Ganshuang bined with entecavir on antiviral therapy of hepatitis B cirrhosis
FANG Rong MA Xiao-yong
Infectious Disease Department, Yan'an People's Hospital;
Abstract:
Objective To investigate the clinical effect of Ganshuang bined with entecavir on antiviral therapy of hepatitis B cirrhosis. Methods A total of 132 hepatitis B cirrhosis patients admitted in our hospital were selected and divided into control group and observation group according to the admission sequences, with 66 cases in each control group was given entecavir antiviral therapy, and the observation group was treated with Ganshuang bined with entecavir antiviral therapy. The clinical effects of the two groups pared between the two The total effective rate of the observation group was %, which was higher than % of the control group (P<) . A